1. Home
  2. GBCI vs SRRK Comparison

GBCI vs SRRK Comparison

Compare GBCI & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glacier Bancorp Inc.

GBCI

Glacier Bancorp Inc.

HOLD

Current Price

$48.82

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$52.86

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBCI
SRRK
Founded
1955
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.8B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
GBCI
SRRK
Price
$48.82
$52.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
13
Target Price
$54.00
$56.17
AVG Volume (30 Days)
1.2M
985.7K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.74%
N/A
EPS Growth
18.45
N/A
EPS
1.38
N/A
Revenue
N/A
N/A
Revenue This Year
$31.52
N/A
Revenue Next Year
$8.46
$534.24
P/E Ratio
$36.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.90
$27.07
52 Week High
$54.58
$58.49

Technical Indicators

Market Signals
Indicator
GBCI
SRRK
Relative Strength Index (RSI) 48.67 44.65
Support Level $49.98 $45.83
Resistance Level $50.40 $51.55
Average True Range (ATR) 1.14 2.10
MACD -0.14 -0.35
Stochastic Oscillator 32.60 33.55

Price Performance

Historical Comparison
GBCI
SRRK

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services through its wholly owned bank subsidiary, Glacier Bank. The group provides a full range of banking services to individuals, small to medium-sized businesses, community organizations, and public entities from several locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, Nevada, and Texas. It offers various banking products and services, including: retail banking, business banking, real estate, commercial, agriculture, and consumer loans; and mortgage origination and loan servicing services, among others.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: